Status:
COMPLETED
Seasonal Allergic Rhinitis In Pediatric Subjects
Lead Sponsor:
GlaxoSmithKline
Conditions:
Rhinitis, Allergic, Perennial
Eligibility:
All Genders
2-12 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine if the investigational drug is effective and safe in children with seasonal allergic rhinitis.
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Diagnosis of seasonal allergic rhinitis.
- Adequate exposure to seasonal (Spring/Summer) allergen prevalent to the geographic area.
- Exclusion criteria:
- Have significant concomitant medical conditions.
- Use of corticosteroids, other allergy meds during the study.
- Have abnormal ECG or laboratory abnormality.
Exclusion
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
End Date :
November 1 2005
Estimated Enrollment :
576 Patients enrolled
Trial Details
Trial ID
NCT00107757
Start Date
March 1 2005
End Date
November 1 2005
Last Update
September 15 2016
Active Locations (65)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Scottsdale, Arizona, United States, 85251
2
GSK Investigational Site
Little Rock, Arkansas, United States, 72202
3
GSK Investigational Site
Costa Mesa, California, United States, 92626
4
GSK Investigational Site
Cudahy, California, United States, 90201